News & Updates

Vitamin D implicated in systemic lupus erythematosus

Patients with systemic lupus erythematosus (SLE) with low levels of vitamin D tend to have a more severe form of the disease, according to a systematic review and meta-analysis.

Coexposure to bisphenols linked to metabolic diseases

A recent study has observed the association of bisphenol A (BPA) and its substitutes with specific metabolic diseases (MDs).

Outcomes after sleeve gastrectomy differ across race, ethnicities

Glycaemic outcomes following sleeve gastrectomy (SG) vary by race and ethnicity, with non-Hispanic Black (NHB) participants showing less favourable outcomes, reports a study.

GLP-1RAs may provide migraine relief independent of weight loss

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have the potential to reduce the frequency of migraines even in patients who do not lose weight—an effect that may be related to a reduction in intracranial pressure, according to a pilot prospective observational study.

A closer look at the safety profile of sitagliptin

GLP-1 RAs reduce glaucoma risk in patients without diabetes

Patients without diabetes who use GLP-1 receptor agonists (RAs) display a lower risk of primary open-angle glaucoma (POAG) and ocular hypertension than those who use other weight-loss therapies at 3- and 5-year intervals, a study has shown.

Obesity tied to target organ damage indices

Obesity shows a significant relationship with several indices of asymptomatic cardiac remodelling and vascular atherosclerosis, according to a study. Moreover, this association is mediated by systolic blood pressure (BP).

Weekly fixed-dosed efsitora as good as daily glargine in T2D

For adult patients with type 2 diabetes (T2D) who are naïve to insulin, a once-weekly fixed-dose efsitora regimen is noninferior to once-daily glargine at reducing blood glucose levels, according to the phase III treat-to-target QWINT-1 trial.

No excess liver cancer risk seen with oral contraceptive use

Two large prospective cohorts show no evidence of an association between the use of oral contraceptives and the risk of liver cancer.

18th Dr Augusto Litonjua Endowed Lectureship: Restriction and weight loss vs. TD2—the latest evidence

How does a regimen of only diet restriction and weight loss fare as an approach to the management of type 2 diabetes (T2D)? Does it work in non-obese individuals?

Prof Roy Taylor, the director of the Newcastle Magnetic Resonance Center, England reviewed the newest evidence in favor of diet replacement and weight loss, during the 18th Dr Augusto Litonjua Endowed Lectureship “Getting Real about Body Mass Index” on November 21, 2024 at Diabetes Philippines’ 41st Annual Convention.